UniSa - IRIS Institutional Research Information System

PAPACCIO, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 468
EU - Europa 89
AS - Asia 11
OC - Oceania 2
SA - Sud America 2
Totale 572
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 467
IT - Italia 28
IE - Irlanda 27
DE - Germania 11
GB - Regno Unito 5
IN - India 4
UA - Ucraina 4
FR - Francia 3
FI - Finlandia 2
HU - Ungheria 2
JP - Giappone 2
AT - Austria 1
AU - Australia 1
BE - Belgio 1
CA - Canada 1
CN - Cina 1
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
LK - Sri Lanka 1
MY - Malesia 1
NL - Olanda 1
NZ - Nuova Zelanda 1
OM - Oman 1
PL - Polonia 1
RO - Romania 1
SE - Svezia 1
TR - Turchia 1
Totale 572
Salva come PNG Salva come JPEG
Città #
Chandler 128
Princeton 95
Ashburn 36
Dublin 27
Andover 24
Redwood City 23
Wilmington 18
Ann Arbor 15
Naples 10
Seattle 8
Washington 4
Aprilia 3
Duncan 3
Edinburgh 3
Houston 3
Norwalk 3
Paris 3
Assago 2
Budapest 2
Castellammare di Stabia 2
Islington 2
Jacksonville 2
New Delhi 2
Pune 2
Rome 2
Tokyo 2
Amsterdam 1
Belvedere Spinello 1
Bogotá 1
Boston 1
Brighton 1
Brussels 1
Böblingen 1
Caserta 1
Chicago 1
Dallas 1
Dambulla 1
Esslingen am Neckar 1
Fairfield 1
Gunzenhausen 1
Helsinki 1
Istanbul 1
Kuala Lumpur 1
Lappeenranta 1
Montreal 1
Mountain View 1
Mugnano di Napoli 1
Munich 1
Pullach im Isartal 1
Quito 1
Reston 1
Salalah 1
San Jose 1
Stockholm 1
Sydney 1
Tallinn 1
Vienna 1
Warsaw 1
West Jordan 1
Totale 457
Salva come PNG Salva come JPEG
Nome #
Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress 46
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer 40
HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy 32
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo 31
Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo 29
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation 28
In the literature: August 2018 28
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer 28
Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development 27
Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells 26
Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: Case report and translational study 26
HGF/MET and the Immune System: Relevance for Cancer Immunotherapy 26
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study 26
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer 26
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization 23
Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells 23
Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy 22
Implication of the Hedgehog pathway in hepatocellular carcinoma 22
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 22
A multicenter, open-label phase II study of metformin with erlotinib in second-line therapy of stage IV non-small-cell lung cancer patients: treatment rationale and protocol dynamics of the METAL trial 21
Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer 19
The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision 16
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction" 14
How organoids can improve personalized treatment in patients with gastro-esophageal tumors 14
Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer 14
Urtica dioica L. inhibits proliferation and enhances cisplatin cytotoxicity in NSCLC cells via Endoplasmic Reticulum-stress mediated apoptosis 12
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 12
Role of HGF-MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer. 11
Will Organoids Fill the Gap towards Functional Precision Medicine? 8
Circulating cancer stem cells: an interesting niche to explore 7
Insulitis in Human Type 1 Diabetic Pancreas: From Stem Cell Grafting to Islet Organoids for a Successful Cell-Based Therapy 7
Mutation tracking in circulating tumour DNA (ctDNA) detects minimal residual disease (MRD) in patients with localized colorectal cancer (CRC) and identifies those at high risk of recurrence regardless of stage, lack of CDX2 expression and CMS subtype 2
Stemness markers of osteosarcoma 2
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC 1
Efficacy of second and third generation EGFR tyrosine kinase inhibitors, alone or in combination, in T790M-mediated resistance 1
Efficacy of osimertinib in combination with Hedgehog pathway inhibitors in reverting T790M-mediated resistence 1
ZNF518B as a transcriptional factor involved in colorectal cancer progression through the epithelial to mesenchymal transition 1
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSCLC cancer: a preliminary study to identify biomarkers of efficacy 1
Effect of MEK inhibition on PD-L1 and MCH-1 expression and on cytokines production profile in NSCLC cells and in human lymphocites 1
Effect of MEK inhibition on PDL1 and and on cytokinesproduction profilein NSCLC cell lines and in human lymphocites 1
Prognostic nutritional index (PNI) is an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer (LAHNSCC) 1
Metastatic colorectal cancer derived organoids recapitulate genomic profile and treatment response of the original tumor 1
A novel ImmunoScore, based on clinical and blood biomarkers, as prognostic model for immunotherapy in NSCLC 1
Results of safety run-in part in Metal (METformin in Advanced Lung cancer) trial 1
Reversion of mesenchymal behaviour by AZD9291 (osimertinib) in EGFR mutant NSCLC cell lines resistant to first generation EGFR tyrosine kinase inhibitors 1
Role of the Hedgehog pathway in preventing occurrence of resistance to first, second, third generation EGFR-TKIs in first line therapy of NSCLC models with EGFR activating mutations 1
New insights from KISS activity: a prognostic biomarker in malignant pleural mesothelioma 1
3D patient-derived gastric cancer organoids as a tool for functional precision medicine for gastric cancer patients 1
Development of a living organoid biobank derived from colorectal cancer patients: Towards personalized medicine 1
Synergistic effect of vismodegib and cisplatin in NSCLC models via autophagy 1
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSLC cancer: a preliminary study to identify biomarkers of efficacy 1
Met/Axl system as a dual target in the mesothelioma pathway and invasiveness 1
Efficacy of sequential treatment with first, second and third generation EGFR inhibitors and role of Hedgehog pathway in the acquisition of resistance in in vivo NSCLC models 1
An integrated analysis of gene expression profile and chromosomal aberrations highlighted the oxidative stress role in anti-HER2 drug-resistant gastric cancer models 1
Patient-derived organoids as a tool for modelling localized colorectal cancer 1
CNAs concordance between CRC-PDOs and the original tissue reveals relevant oncogenic pathways alterations 1
Antitumoral efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models 1
Totale 714
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.538
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.538
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202193 0 0 0 25 30 13 4 1 5 3 9 3
2021/2022127 3 0 2 0 1 0 0 10 26 0 16 69
2022/2023370 26 0 6 42 46 72 6 52 83 2 30 5
2023/2024124 7 14 10 4 10 34 4 8 28 2 3 0
Totale 714